Records released by the U.S. Food and Drug Administration in response to American Oversight’s request for all email communications between agency and White House officials involved in the federal government’s response to the coronavirus outbreak. These records include communications and calendar entries reflecting contact between FDA and White House officials from March to April 2020.

American Oversight has obtained new emails from 2020 in which Trump officials fielded requests from private-sector representatives, in some cases requesting assistance from top public health officials.

American Oversight has obtained records in which Dr. Mehmet Oz asked for federal assistance with obtaining hydroxychloroquine, a drug dubiously promoted by Trump as a coronavirus treatment.

Federal agencies have indicated they are attempting to delay the release of records related to White House efforts to control information — for up to two years.

Joint Status Report filed by American Oversight and the Department of Health and Human Services, the Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, and the Centers for Medicare and Medicaid Services in American Oversight’s lawsuit seeking email communications between agency and White House officials involved in the federal government’s coronavirus response, and any directives, orders, or guidance from HHS or the White House regarding public communications or press strategy.

With three lawsuits and more than 400 public records requests filed, American Oversight intends to get to the bottom of what has been happening behind the scenes in the Trump administration’s mismanaged pandemic response.

American Oversight's lawsuit against the Department of Health and Human Services, the Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, and the Centers for Medicare and Medicaid Services for email communications between agency and White House officials involved in the federal government’s coronavirus response, and any directives, orders, or guidance from HHS or the White House regarding public communications or press strategy.

The uncertainty and fear surrounding the coronavirus have laid bare the deadly consequences of President Donald Trump’s demand for obsequious loyalty and a refusal to take responsibility for mistakes.

FOIA to the U.S. Food and Drug Administration (FDA) seeking all email communications between agency and White House officials involved in the federal government’s response to the coronavirus outbreak.